Table 1. Relationship between ZNF217 and clinicopathologic variables.
Feature | Total number (n) | ZNF217 expression | P value | ||
---|---|---|---|---|---|
High (n) | Low (n) | ||||
Age | |||||
≥70 | 33 | 16 | 17 | 0.79 | |
<70 | 22 | 12 | 10 | ||
Serum PSA | 0.03 | ||||
≥10 | 25 | 17 | 8 | ||
<10 | 30 | 11 | 19 | ||
Gleason score | <0.01 | ||||
≥7 | 18 | 14 | 4 | ||
<7 | 37 | 14 | 23 | ||
T stage | 0.01 | ||||
≥T3 | 15 | 12 | 3 | ||
<T3 | 40 | 16 | 24 | ||
Lymph node metastasis | 0.04 | ||||
Presence | 11 | 9 | 2 | ||
Absence | 44 | 19 | 25 | ||
Biochemical recurrence | 0.04 | ||||
Presence | 16 | 12 | 4 | ||
Absence | 39 | 16 | 23 |